HEMODIALYSIS ACCESS GRAFT MARKET ANALYSIS

Hemodialysis Access Graft Market, by Material (Biological Grafts, Synthetic Grafts and Biosynthetic Grafts), By End Users (Hospital, Dialysis Centers, Ambulatory Surgical Centers, Clinics, and Home Care Settings), and By Region - Size, Share, Outlook, and Opportunity Analysis, 2022-2028

To Be Published : Dec 2024
Code : CMI1840
Formats :
Excel and PDF
Industry : Biotechnology

Leading Companies

Hemodialysis Access Graft Market – Competitive Analysis

Key players operating in the global hemodialysis access graft market are W.L. Gore & Associated, C. R. Bard, Merit Medical Systems, Inc. and Getinge Group.

Companies are focusing on acquiring complementary business or products to enter the market. For instance, in 2016, Merit Medical Systems, Inc., a manufacturer and marketer of proprietary disposable medical devices used for interventional and diagnostic procedures, acquired HeRO Graft and its related assets from Cryolife, Inc., for US$ 18.5 million. Furthermore, in 2011, Atrium Medical was acquired by Getinge Group for US$ 680 million. The acquisition of Atrium is a strategic move by Getinge Group to leverage scientific and technological advances of both the companies and company will also get access to vascular grafts of Atrium Medical.